08045479576
08045479576
Buparvaquone Powder
25.00 - 50.00 INR/Kilograms
Product Details:
- Smell No Smell
- Shelf Life 12 Months
- Purity(%) 100%
- Physical Form Powder
- Click to View more
-
Share Your Product:
X
Buparvaquone Powder Price And Quantity
- 50 Kilograms
- 25.00 - 50.00 INR/Kilograms
Buparvaquone Powder Product Specifications
- 12 Months
- Powder
- No Smell
- 100%
Buparvaquone Powder Trade Information
- Cash Advance (CA) Cash in Advance (CID)
- 1000 Kilograms Per Day
- 7 Days
- Western Europe Australia Central America Middle East South America Asia Eastern Europe North America Africa
Product Description
Our company, Shreeji Pharma International, is a leading manufacturer of buparvaquone in Gujarat. India. WeThe professionals manufacture products under a GMP site with full regulatory support. It is a hydroxynaphthoquinone antiprotozoal similar to parvaquone and atovaquone. It is a promising compound for the therapy and prophylaxis of all kinds of theileriosis. It has been shown that buparvaquone has anti-leishmanial activity in vitro. As of today, Shreeji Pharma International exports Buparvaquone to countries in the Gulf, South East Asia, Africa, CIS, LATAM, Central America and Europe.
Properties:
- Name: Buparvaquone
- CAS No.: 88426-33-9
- Formula: C21H26O3
- Molecular Weight: 326.43
- Synonyms: 2-((4-tert-Butylcyclohexyl)methyl)-3-hydroxy-1,4-naphthochinon;1,4-Naphthalenedione, 2-((4-(1,1-dimethylethyl)cyclohexyl)methyl)-3-hydroxy-;Buparvaquone [BAN:INN];4-hydroxy-3-[(4-tert-butylcyclohexyl)methyl]naphthalene-1,2-dione;Buparvacuona [Spanish];Butalex;BW 720C; 2-((4-(1,1-Dimethylethyl)cyclohexyl)methyl)-3-hydroxy-1,4-naphthalenedione;2-((4-tert-Butylcyclohexyl)methyl)-3-hydroxy-1,4-naphthoquinone;(RS,RS,RS,RS)-2-((4-tert-Butylcyclohexyl)methyl)-3-hydroxy-1,4-naphthoquinone;Buparvaquonum [Latin];
- Density: 1.158 g/cm3
- Melting Point: 178-184 °C
- Boiling Point: 460.687 °C at 760 mmHg
- Flash Point: 246.536 °C
- Appearance: Yellow crystalline solid
How does it work?
It is currently being evaluated for use in treatment and prophylaxis of theileriosis. In vitro, buparvaquone is anti-leishmanial. Along with other known substances, it can treat bovine East Coast fever protozoa in vitro.
Manufacturing process:
A preparation method for buparvaquone is disclosed in the invention, which relates to medicine synthesis. Preparation involves: starting with 1,4-benzopyran diketone and p-tert-butylcyclohexyl acetaldehyde, then performing condensation and rearrangement to produce pharmaceutical grade buparvaquone. Buparvaquone can be prepared using the invention without using an expensive catalyst, and its synthesis yield is increased by approximately 65% compared to prior art. Additionally, the route is environment-friendly and industrially feasible.
How to use:
A veterinarian should administer injections of buparvaquone into the neck muscles. If it is severe, the treatment can be repeated every 48 to 72 hours. At the injection site, administer only 10 ml per injection.
Side effects:
Sometimes, thin-skinned animals may develop localized, painless, edematous swelling points at the injection site.
Warnings and precautions while using this product
Breathing mist or vapors is not recommended. Do not swallow them. Avoid getting them in your eyes. After handling, wash your skin thoroughly.
Tell us about your requirement
Price:
Quantity
Select Unit
- 50
- 100
- 200
- 250
- 500
- 1000+
Additional detail
+91
Email
Other Products in 'Active Pharmaceuticals Ingredients (API)' category
Contact Us
- 311, Atlantis Heights, Sarabhai Main Road, Vadiwadi,Vadodara - 390007, Gujarat, India
- Phone :08045479576
-
Send Inquiry
Mr. Nilesh Bansilal Sheth (Partner)
Mobile :08037400111
: nilesh.sheth70
MR. Tushar V. Kavade (Partner) : tushar.kavade
Send Inquiry
|
SHREEJI PHARMA INTERNATIONAL
All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Private Limited.
Developed and Managed by Infocom Network Private Limited.
